Comprehensive Physiology Wiley Online Library
For Librarians For Authors Editors About

Chemical Mediators of Immediate Hypersensitivity Reactions

Jeffrey M. Drazen

10.1002/cphy.cp030340

Source: Supplement 12: Handbook of Physiology, The Respiratory System, Mechanics of Breathing

Originally published: 1986

Published online: January 2011

Full Article on Wiley Online Library



Abstract

The sections in this article are:

1 Mediator Concept
2 Mediators: Release and Control
3 Pharmacology of Mediators with Action on Airway Smooth Muscle
3.1 Primary Mediators
3.2 Newly Generated Mediators
4 Summary
References
 1. Adams, G. K., III, and L. Lichtenstein. In vitro studies of antigen‐induced bronchospasm: effect of antihistamine and SRS‐A antagonist on response of sensitized guinea pig and human airways to antigen. J. Immunol. 122: 555–562, 1979.
 2. Adolphson, R. L., and R. G. Townley. Comparison of the bronchodilator activities of isoproterenol and of prostaglandin E1 aerosols. Chest 63: 55–65, 1973.
 3. Anngard, E., and B. Samuelsson. Biosynthesis of prostaglandins from arachidonic acid in guinea pig lung. J. Biol. Chem. 240: 3518–3521, 1965.
 4. Antonissen, L. A., R. W. Mitchell, E. A. Kroeger, W. Kepron, N. L. Stephens, and J. Bergen. Histamine pharmacology in airway smooth muscle from a canine model of asthma. J. Pharmacol. Exp. Ther. 213: 150–155, 1980.
 5. Ash, A. S. F., and H. O. Schild. Receptors mediating some actions of histamine. Br. J. Pharmacol. Chemother. 27: 427–439, 1966.
 6. Assem, E. S. K., and H. O. Schild. Inhibition by sympathomimetic amines of histamine release induced by antigen in passively sensitized human lung. Nature London 224: 1028–1029, 1969.
 7. Auer, J. The effect of vagus section upon anaphylaxis in guinea pigs. J. Exp. Med. 12: 638–648, 1910.
 8. Auer, J., and P. A. lewis. The physiology of the immediate reaction of anaphylaxis in the guinea pig. J. Exp. Med. 12: 151–175, 1910.
 9. Becker, E. L., and P. M. Henson. In vitro studies of immunologically induced secretion of mediators from cells and related phenomena. Adv. Immunol. 17: 93–193, 1973.
 10. Black, J. W., W. A. M. Duncan, C. J. Durant, C. R. Ganellin, and E. M. Parsons. Definition and antagonism of histamine H2‐receptors. Nature London 236: 385–390, 1972.
 11. Boot, J. R., W. Dawson, A. F. Cockerill, D. N. B. Mullen, and D. J. Osborne. The pharmacology of prostaglandin‐like substances released from guinea pig lungs during anaphylaxis. Prostaglandins 13: 927–932, 1978.
 12. Brocklehurst, W. E. The release of histamine and formation of a slow‐reacting substance (SRS‐A) during anaphylactic shock. J. Physiol. London 151: 416–435, 1960.
 13. Brown, N. E., E. R. McFadden, Jr., and R. H. Ingram, Jr. Airway responses to inhaled histamine in asymptomatic smokers and nonsmokers. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 42: 508–513, 1977.
 14. Brown, R., R. H. Ingram, Jr., and E. R. McFadden, Jr. Effects of prostaglandin F2α on lung mechanics in nonasthmatic and asthmatic subjects. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 44: 150–155, 1978.
 15. Brown, R., R. H. Ingram, Jr., J. J. Wellman, and E. R. McFadden, Jr. Effects of intravenous histamine on pulmonary mechanics in nonasthmatic and asthmatic subjects. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 42: 221–227, 1977.
 16. Castillo, J. C., and E. J. DeBeer. The tracheal chain. I. A preparation for the study of antispasmodics with particular reference to bronchodilator drugs. J. Pharmacol. Exp. Ther. 90: 104–109, 1947.
 17. Caulfield, J. P., R. Lewis, A. Hein, and K. F. Austen. Secretion in dissociated human pulmonary mast cells. J. Cell Biol. 85: 299–312, 1980.
 18. Chand, N. In vitro anaphylaxis in guinea‐pig lung: evidence for the protective role of histamine H2‐receptors. Eur. J. Pharmacol. 55: 337–339, 1979.
 19. Chand, N., and L. DeRoth. Actions of histamine and other substances on the airway smooth muscle of swine (in vitro). Vet. Sci. Commun. 2: 151–155, 1978.
 20. Chand, N., and L. DeRoth. Pharmacological characterization of the rabbit lung strip. Res. Commun. Chem. Pathol. Pharmacol 23: 223–232, 1979.
 21. Chand, N., and L. DeRoth. Responses of guinea‐pig lung parenchymal strips to prostaglandins and some selected autocoids. J. Pharm. Pharmacol. 31: 712–714, 1979.
 22. Chand, N., B. N. Dhawan, R. C. Srimal, N. H. Rahmani, R. K. Shukla, and B. M. Altura. Reactivity of trachea, bronchi, and lung strips to histamine and carbachol in rhesus monkeys. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 49: 729–734, 1980.
 23. Chand, N., and P. Eyre. Classification and biological distribution of histamine receptor sub‐types. Agents Actions 5: 277–295, 1975.
 24. Chand, N., and P. Eyre. Spasmolytic action of histamine in airway smooth muscle of horse. Agents Actions 8: 191–198, 1978.
 25. Church, M. K. Response of rat lung to humoral mediators of anaphylaxis and its modification by drugs and sensitization. Br. J. Pharmacol. 55: 423–430, 1975.
 26. Colebatch, H. J. H., C. R. Olsen, and J. A. Nadel. Effect of histamine, serotonin, and acetylcholine on the peripheral airways. J. Appl. Physiol. 21: 217–226, 1966.
 27. Collier, H. O. J. Kinins and ventilation of the lungs. In: Handbook of Experimental Pharmacology. Berlin: Springer‐Verlag, 1970, vol. 23, p. 409–420.
 28. Corey, E. J., D. A. Clark, G. Goto, A. Marfat, C. Mioskowski, B. Samuelsson, and S. Hammarstrom. Stereospecific total synthesis of a “slow‐reacting substance of anaphylaxis” (SRS‐A), leukotriene C‐1. J. Am. Chem. Soc. 102: 1436–1439, 1980.
 29. Cuthbert, M. F. Effect on airway resistance of PGE1 given by aerosol to healthy and asthmatic volunteers. Br. Med. J. 4: 723–726, 1969.
 30. Dale, H. H., and P. P. Laidlaw. The physiologic action of β‐imidazolylethylamine. J. Physiol. London 41: 318–344, 1910.
 31. DeKock, M. A., J. A. Nadel, S. Zwi, H. J. H. Colebatch, and C. R. Olsen. New method for perfusing bronchial arteries: histamine bronchoconstriction and apnea. J. Appl. Physiol. 21: 185–194, 1966.
 32. Demopoulos, C. A., R. N. Pinckard, and D. J. Hanahan. Platelet‐activating factor. Evidence for 1‐O‐alkyl‐2‐acetyl‐sn‐glyceryl‐3‐phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 254: 9355–9358, 1979.
 33. Douglas, J. S., M. W. Dennis, P. Ridgway, and A. Bouhuys. Airway dilation and constriction in spontaneously breathing guinea pigs. J. Pharmacol. Exp. Ther. 180: 98–109, 1972.
 34. Drazen, J. M., and K. F. Austen. Effects of intravenous administration of slow‐reacting substance of anaphylaxis, histamine, bradykinin and prostaglandin F2α on pulmonary mechanics in the guinea pig. J. Clin. Invest. 53: 1679–1685, 1974.
 35. Drazen, J. M., K. F. Austen, R. A. Lewis, D. A. Clark, G. Goto, A. Marfat, and E. J. Corey. Comparative airway and vascular activities of leukotrienes C‐1 and D in vivo and in vitro. Proc. Natl. Acad. Sci. USA 77: 4354–4358, 1980.
 36. Drazen, J. M., R. A. Lewis, S. I. Wasserman, R. P. Orange, and K. F. austen. Differential effects of a partially purified preparation of slow‐reacting substance of anaphylaxis (SRS‐A) on guinea pig tracheal spirals and parenchymal strips. J. Clin. Invest. 63: 1–5, 1979.
 37. Drazen, J. M., and M. W. Schneider. Comparative responses of tracheal spirals and parenchymal strips to histamine and carbachol in vitro. J. Clin. Invest. 61: 1441–1447, 1978.
 38. Dunlop, L. S., A. P. Smith, and P. J. Piper. The effect of histamine antagonists on antigen‐induced contractions of sensitized human bronchus in vitro (Abstract). Br. J. Pharmacol. 59: 475P, 1977.
 39. Eyre, P. Histamine H2‐receptors in the sheep bronchus and cat trachea: the action of burimamide. Br. J. Pharmacol. 48: 321–323, 1973.
 40. Farmer, J. B., I. M. Richards, P. Sheard, and A. M. Woods. Mediators of passive lung anaphylaxis in the rat. Br. J. Pharmacol. 55: 57–64, 1975.
 41. Fleisch, J. H., and P. J. Calkins. Comparison of drug‐induced responses of rabbit trachea and bronchus. J. Appl. Physiol. 41: 62–66, 1976.
 42. Ganellin, C. R., G. J. Durant, and J. C. Emmett. Some chemical aspects of histamine H2‐receptor antagonists. Federation Proc. 35: 1924–1930, 1976.
 43. Ghelceni, A. M., M. C. Holroyde, and P. Sheard. Response of human isolated bronchial and lung parenchymal strips to SRS‐A and other mediators of asthmatic bronchospasm. Br. J. Pharmacol. 71: 107–112, 1980.
 44. Godfroid, J.‐J., F. Heymans, E. Michel, C. Redeuilh, E. Steiner, and J. Benveniste. Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl choline. FEBS Lett. 116: 161–164, 1980.
 45. Hamberg, M., P. Hedqvist, K. Strandberg, J. Svensson, and B. Samuelsson. Prostaglandin endoperoxides. IV. Effects on smooth muscle. Life Sci. 16: 451–462, 1975.
 46. Hamberg, M., and B. Samuelsson. Prostaglandin endoperoxides. VII. Novel transformations of arachidonic acid in guinea pig lung. Biochem. Biophys. Res. Commun. 61: 942–949, 1974.
 47. Hamberg, M., J. Svensson, and B. Samuelsson. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. USA 72: 2994–2998, 1975.
 48. Hamberg, M., J. Svensson, T. Wakabayshi, and B. Samuelsson. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. USA 71: 345–349, 1974.
 49. Hanna, C. J., M. R. Boch, P. D. Paré, and R. R. Schellenberg. Slow‐reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature London 290: 343–344, 1981.
 50. Hanna, C. J., and S. H. Roth. The guinea pig tracheobronchial spiral strip: responses to selected agonists. Can. J. Physiol. Pharmacol. 56: 823–827, 1978.
 51. Hedqvist, P., S.‐E. Dahlen, L. Gustafsson, S. Hammarstrom, and B. Samuelsson. Biological profile of leukotrienes C4 and D4. Acta Physiol. Scand. 110: 331–333, 1980.
 52. Hedqvist, P., A. Holmgren, and A. A. Mathe. Effect of prostaglandin F2α on airway resistance in man (Abstract). Acta Physiol. Scand. 82: 29A, 1971.
 53. Herxheimer, H. Bronchial obstruction induced by allergens, histamine, and acetyl‐beta methylcholine chloride. Int. Arch. Allergy Appl. Immunol. 2: 27–39, 1951.
 54. Herxheimer, H., and I. Roetscher. Effects of prostaglandin E1 on lung function in bronchial asthma. Eur. J. Clin. Pharmacol. 3: 123–125, 1971.
 55. Hirata, F., and J. Axelrod. Phospholipid methylation and biological signal transmission. Science 209: 1082–1090, 1980.
 56. Ho, P. C., R. A. Lewis, K. F. Austen, and R. P. Orange. Mediators of immediate hypersensitivity. In: Comprehensive Immunology: Cellular, Molecular, and Clinical Aspects of Allergic Disorders, edited by S. Gupta and R. A. Good. New York: Plenum, 1979, vol. 6, p. 179–228.
 57. Holgate, S. T., R. A. Lewis, and K. F. Austen. 3′,5′‐Cyclic adenosine monophosphate‐dependent protein kinase of the rat serosal mast cell and its immunologic activation. J. Immunol. 124: 2093–2099, 1980.
 58. Holgate, S. T., R. A. Lewis, and K. F. Austen. Mast cell activation and secretion. In: New Trends in Allergy, edited by J. Ring and C. Burg. Berlin: Springer‐Verlag, 1981, p. 9–19.
 59. Holgate, S. T., R. A. Lewis, J. F. Maguire, L. J. Roberts II, J. A. Oates, and K. F. Austen. Effects of prostaglandin D2 on rat serosal mast cells: discordance between immunologic mediator release and cyclic AMP levels. J. Immunol. 125: 1367–1373, 1980.
 60. Holroyde, M. C., R. E. C. Altounyan, M. Cole, M. Dixon, and E. V. Elliott. Bronchoconstriction produced in man by leukotrienes C and D. Lancet 2: 17–18, 1981.
 61. Ishizaka, K., and T. Ishizaka. Identification of IgE‐antibodies as a carrier of reagenic activity. J. Immunol. 99: 1187–1198, 1967.
 62. Ishizaka, T., and K. Ishizaka. Triggering of histamine release from rat mast cells by divalent antibodies against IgE‐receptor. J. Immunol. 120: 800–805, 1978.
 63. Ishizaka, T., K. Ishizaka, R. P. Orange, and K. F. Austen. The capacity of human immunoglobulin E to mediate the release of histamine and slow‐reacting substance of anaphylaxis (SRS‐A) from monkey lung. J. Immunol. 104: 335–343, 1970.
 64. Kadowitz, P. J., B. M. Chapnick, L. P. Feigen, A. L. Hyman, P. K. Nelson, and E. W. Spannhake. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 45: 408–413, 1978.
 65. Kadowitz, P. J., C. A. Gruetter, D. B. McNamara, R. R. Gorman, E. W. Spannhake, and A. L. Hyman. Comparative effects of endoperoxide PGH2 and an analog on the pulmonary vascular bed. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 42: 953–958, 1977.
 66. Kelleway, C. H., and E. R. Trethewie. The liberation of a slow‐reacting smooth‐muscle‐stimulating substance in anaphylaxis. Q. J. Exp. Physiol. 30: 121–145, 1940.
 67. Kennerly, D. A., T. J. Sullivan, and C. W. Parker. Activation of phospholipid metabolism during mediator release from stimulated rat mast cells. J. Immunol. 122: 152–159, 1979.
 68. Kennerly, D. A., T. J. Sullivan, P. Sylvester, and C. W. Parker. Diacylglycerol metabolism in mast cells: a potential role in membrane fusion and arachidonic acid release. J. Exp. Med. 150: 1039–1044, 1979.
 69. Krell, R. D. Pharmacologic characterization of isolated canine bronchial smooth muscle. Eur. J. Pharmacol. 49: 151–155, 1978.
 70. Lapetina, E. G., M. M. Billah, and P. Cuatrecasas. The phosphatidylinositol cycle and the regulation of arachidonic acid production. Nature London 292: 367–369, 1981.
 71. Large, B. J., P. F. Leswell, and D. R. Maxwell. Bronchodilator activity of an aerosol of prostaglandin E1 in experimental animals. Nature London 224: 78–80, 1969.
 72. Lewis, R. A., and K. F. Austen. Mediation of local hemeostasis and inflammation by leukotrienes and other mast cell dependent compounds. Nature London 293: 103–108, 1981.
 73. Lewis, R. A., K. F. Austen, J. M. Drazen, D. A. Clark, A. Marfat, and E. J. Corey. Slow‐reacting substance of anaphylaxis: identification of leukotrienes C‐1 and D from human and rat sources. Proc. Natl. Acad. Sci. USA 77: 3710–3714, 1980.
 74. Lewis, R. A., J. M. Drazen, K. F. Austen, D. A. Clark, and E. J. Corey. Identification of the C(6)‐S‐conjugate of leukotriene A with cysteine as a naturally occurring slow‐reacting substance of anaphylaxis (SRS‐A): importance of the 11‐cis‐geometry for biological activity. Biochem. Biophys. Res. Commun. 96: 271–277, 1980.
 75. Lewis, R. A., S. I. Wasserman, E. J. Goetzl, and K. F. Austen. Formation of slow‐reacting substance of anaphylaxis in human lung tissue and cells before release. J. Exp. Med. 140: 1133–1146, 1974.
 76. Loring, S. H., J. M. Drazen, and R. H. Ingram, Jr. Canine pulmonary response to aerosol histamine: direct versus vagal effects. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 42: 946–952, 1977.
 77. Loring, S. H., J. M. Drazen, J. C. Smith, and F. G. Hoppin, Jr. Vagal stimulation and aerosol histamine increase hysteresis of lung recoil. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 51: 477–484, 1981.
 78. Loring, S. H., R. H. Ingram, Jr., and J. M. Drazen. Effects of lung inflation on airway and tissue responses to aerosol histamine. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 51: 806–811, 1981.
 79. Main, I. H. M. The inhibitory actions of prostaglandins on respiratory smooth muscle. Br. J. Pharmacol. Chemother. 22: 511–519, 1964.
 80. Mathe, A. A., and P. Hedqvist. Effect of prostaglandins F2α and E2 on airway conductance in healthy subjects and asthmatic patients. Am. Rev. Respir. Dis. 111: 313–320, 1975.
 81. McFadden, E. R., Jr., and K. F. Austen. Bronchial asthma. In: Harrison's Principles of Internal Medicine (9th ed.), edited by M. M. Wintrobe, G. W. Thorn, R. D. Adams, E. Braunwald, K. J. Isselbacher, and R. G. Petersdorf. Boston, MA: McGraw‐Hill, 1980, p. 1203–1210.
 82. McManus, L. M., D. J. Hanahan, C. A. Demopoulos, and R. N. Pinckard. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorycholine (AGEPC), a synthetic platelet‐activating factor (PAF), in the rabbit. J. Immunol. 124: 2919–2924, 1980.
 83. McQueen, D. S. The effects of some prostaglandins on respiration in anaesthetised cats. Br. J. Pharmacol. 50: 559–568, 1974.
 84. Michoud, M. C., P. D. Paré, R. P. Orange, and J. C. Hogg. Airway sensitivity to slow‐reacting substance of anaphylaxis, histamine, and antigen in Ascaris sensitive monkeys. Am. Rev. Respir. Dis. 119: 419–424, 1979.
 85. Murphy, R. C., S. Hammarstrom, and B. Samuelsson. Leukotriene C: a slow‐reacting substance from murine mastocytoma cells. Proc. Natl. Acad. Sci. USA 76: 4275–4279, 1979.
 86. Nadel, J. A., and D. F. Tierney. Effect of a previous deep inspiration on airway resistance in man. J. Appl. Physiol. 16: 717–719, 1961.
 87. Newball, H. H., and C. J. Lenfant. The influence of atropine and cromolyn on human bronchial hyperreactivity to aerosolized prostaglandin F2α. Respir. Physiol. 30: 125–136, 1977.
 88. Newball, H. H., R. C. Talamo, and L. M. Lichtenstein. Anaphylactic release of a basophil kallikrein‐like activity. II. A mediator of immediate hypersensitivity reactions. J. Clin. Invest. 64: 466–475, 1979.
 89. Orange, R. P. Dissociation of the immunologic release of histamine and slow reacting substance of anaphylaxis from human lung using cytochalasins A & B. J. Immunol. 114: 182–186, 1975.
 90. Orange, R. P., and K. F. Austen. Slow reacting substance of anaphylaxis. Adv. Immunol. 10: 105–144, 1969.
 91. Orange, R. P., W. G. Austen, and K. F. Austen. Immunological release of histamine and slow‐reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3′,5′‐adenosine monophosphate. J. Exp. Med. 134, Suppl.: 136s–148s, 1971.
 92. Orning, L., S. Hammarstrom, and B. Samuelsson. Leukotriene D: a slow reacting substance from rat basophilic leukemia cells. Proc. Natl. Acad. Sci. USA 77: 2014–2017, 1980.
 93. Pace‐Asciak, C. R. Oxidative biotransformations of arachidonic acid. Prostaglandins 13: 811–817, 1977.
 94. Parker, C. D., R. E. Bilbo, and C. E. Reed. Methacholine aerosol as a test for bronchial asthma. Arch. Intern. Med. 115: 452–458, 1965.
 95. Parker, C. W., S. F. Falkenheim, and M. M. Huber. Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl‐glycine and cysteine in rat basophilic leukemia cells stimulated with A‐23187. Prostaglandins 20: 863–886, 1980.
 96. Parratt, J. R., and G. B. West. 5‐Hydroxytryptamine and tissue mast cells. J. Physiol. London 137: 169–178, 1957.
 97. Patterson, R., and C. H. Talbot. Respiratory responses in subhuman primates with immediate type hypersensitivity. J. Lab. Clin. Med. 73: 924–933, 1969.
 98. Pinckard, R. N., R. S. Farr, and D. J. Hanahan. Physicochemical and functional identity of rabbit platelet‐activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J. Immunol. 123: 1847–1857, 1979.
 99. Rahamimoff, R., and I. Bruderman. Changes in pulmonary mechanics induced by serotonin. Life Sci. 4: 1383–1389, 1965.
 100. Reid, G., and M. Rand. Pharmacological actions of 5‐hydroxytryptamine (serotonin, thrombocytin). Nature London 169: 801–802, 1952.
 101. Riley, J. F., and G. B. West. The presence of histamine in tissue mast cells. J. Physiol. London. 120: 528–537, 1953.
 102. Rosenthale, M. E., A. Dervinis, and J. Kassarich. Bronchodilator activity of the prostaglandins E1 and E2. J. Pharmacol. Exp. Ther. 178: 541–548, 1971.
 103. Sadavongvivad, C. Pharmacological significance of biogenic amines in the lungs: 5‐hydroxytryptamine. Br. J. Pharmacol. 38: 353–365, 1970.
 104. Schneider, M. W., and J. M. Drazen. Comparative in vitro effects of arachidonic acid metabolites on tracheal spirals and parenchymal strips. Am. Rev. Respir. Dis. 121: 835–842, 1980.
 105. Segal, D. M., J. D. Taurog, and H. Metzger. Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc. Natl. Acad. Sci. USA 74: 2993–2997, 1977.
 106. Sinha, Y. K., and G. B. West. The antagonism between local anesthetic drugs and 5‐hydroxytryptamine. J. Pharm. Pharmacol. 5: 370–374, 1953.
 107. Smith, A. P., and M. F. Cuthbert. Antagonistic action of aerosols of prostaglandins F2α and E2 on bronchial muscle tone in man. Br. Med. J. 3: 212–213, 1972.
 108. Snapper, J. R., J. M. Drazen, S. H. Loring, P. S. Braasch, and R. H. Ingram, Jr. Vagal effects on histamine, carbachol, and prostaglandin F2α responsiveness in the dog. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 47: 13–16, 1979.
 109. Snapper, J. R., J. M. Drazen, S. H. Loring, W. Schneider, and R. H. Ingram, Jr. Distribution of pulmonary responsiveness to aerosol histamine in dogs. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 44: 738–742, 1978.
 110. somlyo, A. P., and A. V. somlyo. Biophysics of smooth muscle excitation and contraction. In: Airway Dynamics: Physiology and Pharmacology, edited by A. Bouhuys. Springfield, IL: Thomas, 1970, p. 209–227.
 111. Spannhake, E. W., R. J. Lemen, M. J. Wegmann, A. L. Hyman, and P. J. Kadowitz. Effects of arachidonic acid and prostaglandins on lung function in the intact dog. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 44: 397–405, 1978.
 112. Spannhake, E. W., R. J. Lemen, M. J. Wegmann, A. L. Hyman, and P. J. Kadowitz. Analysis of airway effects of a PGH2 analog in the anesthetized dog. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 44: 406–415, 1978.
 113. Stotland, L. M., and N. N. Share. Pharmacological studies on active bronchial anaphylaxis in the rat. Can. J. Physiol. Pharmacol 52: 1119–1125, 1974.
 114. Strandberg, K., and P. Hedqvist. Airway effects of slow‐reacting substance, prostaglandin F2 and histamine in the guinea pig. Acta Physiol. Scand. 94: 105–111, 1975.
 115. Sullivan, T. J., K. L. Parker, S. A. Eisen, and C. W. Parker. Modulation of cyclic AMP in purified rat mast cells. II. Studies on the relationship between intracellular cyclic AMP concentration and histamine release. J. Immunol. 114: 1480–1485, 1975.
 116. Svensson, J., K. Strandberg, T. Tuvemo, and M. Hamberg. Thromboxane A2: effects on airway and vascular smooth muscle. Prostaglandins 14: 425–436, 1977.
 117. Sweatman, W. J. F., and H. O. J. Collier. Effects of prostaglandins on human bronchial muscle. Nature London 217: 69–70, 1968.
 118. Thulesius, O., J. Boe, and E. Berlin. Physiological and pharmacological studies on isolated human bronchial preparations. Scand. J. Respir. Dis. 59: 66–74, 1978.
 119. Townley, R. G., M. Denniss, and H. H. Itkin. Comparative action of acetyl‐beta methylcholine, histamine, and pollen antigens in subjects with hay fever and patients with bronchial asthma. J. Allergy 36: 121–137, 1965.
 120. Vargaftig, B. B., J. Lefort, M. Chignard, and J. Benveniste. Platelet‐activating factor induces a platelet‐dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur. J. Pharmacol. 65: 185–192, 1980.
 121. Wasserman, M. A. Bronchopulmonary effects of prostaglandin F2α and three of its metabolites in the dog. Prostaglandins 9: 959–973, 1975.
 122. Wasserman, M. A. Bronchopulmonary responses to prostaglandin F2α histamine, and acetylcholine in the dog. Eur. J. Pharmacol. 32: 146–155, 1975.
 123. Wasserman, M. A. Bronchopulmonary pharmacology of some prostaglandin endoperoxide analogs in the dog. Eur. J. Pharmacol. 36: 103–114, 1976.
 124. Wasserman, M. A., D. W. DuCharme, R. L. Griffin, G. L. DeGraaf, and F. G. robinson. Bronchopulmonary and cardiovascular effects of PGD2 in the dog. Prostaglandins 13: 255–269, 1977.
 125. Wasserman, M. A., D. W. DuCharme, M. G. Wendling, R. L. Griffin, and G. L. DeGraaf. Bronchodilator effects of prostacyclin (PGI2) in dogs and guinea pigs. Eur. J. Pharmacol 66: 53–63, 1980.
 126. Wasserman, M. A., and R. L. Griffin. Thromboxane B2‐comparative bronchoactivity in experimental systems. Eur. J. Pharmacol. 46: 303–313, 1977.
 127. Wasserman, M. A., R. L. Griffin, and F. B. Marsalisi. Inhibition of bronchoconstriction by aerosols of prostaglandins E1 and E2. J. Pharmacol Exp. Ther. 214: 68–73, 1980.
 128. Weiss, J. W., J. M. Drazen, N. Coles, E. R. McFadden, Jr., R. Lewis, P. Weller, E. J. Corey, and K. F. Austen. Bronchoconstrictor effects of leukotriene C in humans. Science 216: 196–198, 1982.
 129. Windaus, A., and W. Vogt. Synthese des imidazolyl‐athylamins. Ber. Dtsch. Chem. Ges. 40: 3691–3695, 1907.
 130. Yamatake, Y., S. Sasagawa, and S. Yanaura. Drug responses of canine trachea, bronchus and bronchiole. Chem. Pharm. Bull. 26: 318–321, 1978.

Contact Editor

Submit a note to the editor about this article by filling in the form below.

* Required Field

Article Title: Chemical Mediators of Immediate Hypersensitivity Reactions
 

How to Cite

Jeffrey M. Drazen. Chemical Mediators of Immediate Hypersensitivity Reactions. Compr Physiol 2011, Supplement 12: Handbook of Physiology, The Respiratory System, Mechanics of Breathing: 711-718. First published in print 1986. doi: 10.1002/cphy.cp030340